Target intelligence / Profile preview

Activator of transcription and developmental regulator AUTS2 (AUTS2)

Target
AUTS2
Molecular classification
Transcription factor, Chromatin-associated protein, RNA-binding protein
01

Overview

Activator of transcription and developmental regulator AUTS2 (AUTS2) is a nuclear protein encoded by the AUTS2 gene on human chromosome 7q11.22, comprising 19 exons that produce multiple isoforms via alternative splicing and transcription start sites. The protein localizes primarily to the nucleus and regulates gene transcription—most notably, it associates with non-canonical Polycomb Repressive Complex 1 (PRC1) and shifts the complex from a repressor to a transcriptional activator, crucial for central nervous system development. AUTS2 also plays roles in RNA metabolism, evidenced by interactions with RNA-binding proteins and possible direct RNA binding, and in cytoskeletal remodeling in the cytoplasm via activation of Rac1. Loss-of-function mutations or deletions cause neurodevelopmental syndromes (AUTS2 syndrome) characterized by intellectual disability, microcephaly, and distinctive behavioral and morphological features. Although involved in disease, AUTS2 itself is not a conventional druggable target but serves as a key biomarker and mechanistic gene in neurodevelopmental pathology.

Other names
Autism susceptibility gene 2 proteinKIAA0442FBRSL2MRD26autism susceptibility candidate 2autism-related protein 1
02

Biological functions

Transcriptional regulationEpigenetic regulation (via Polycomb complexes)RNA metabolism (potential, via interaction with RNA-binding proteins)Regulation of neural differentiation and neurodevelopmentCytoskeletal organization (Rac1 pathway, actin remodeling)
03

Disease associations

Neurodevelopmental disorders (autism spectrum disorders, intellectual disability, developmental delay)Acute lymphoblastic leukemiaCertain cancersSkin agingEarly-onset androgenetic alopecia
04

Safety considerations

Mutations can cause AUTS2 syndrome, with symptoms including intellectual disability, microcephaly, behavioral abnormalities, and craniofacial dysmorphismTherapeutic manipulation challenging due to complex neurodevelopmental roles and potential off-target effects
05

Biomarkers

Mutations/variants in AUTS2 (used in diagnosis and understanding of AUTS2 syndrome and related neurodevelopmental disorders)

Beyond the preview

Go deeper on Activator of transcription and developmental regulator AUTS2 (AUTS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Activator of transcription and developmental regulator AUTS2 (AUTS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call